ArticleActa pharmacologica Sinica2025

Somatostatin receptor 2 targeting peptide modifications for peptide-drug conjugate treatment of small cell lung cancer.

Qing Bo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.